Fund Managers’ Favourites: Hot Healthcare

AXA Framlington fund manager, Gemma Game, discusses her favourite opportunities in the dynamic and ever-changing global healthcare industry

Alanna Petroff 5 February, 2013 | 6:00AM
Facebook Twitter LinkedIn

In the video series, "Fund Managers' Favourites", Morningstar speaks with UK-based fund managers to learn about their top investment picks. In this video, Morningstar journalist Alanna Petroff speaks with AXA Framlington fund manager, Gemma Game, about her top picks in the healthcare industry. Game runs the AXA Framlington Biotech fund and the AXA Framlington Health fund.

Transcript:

Alanna Petroff: Healthcare is a dynamic industry that's driven by research and innovation. Within the healthcare investment space, there’s the big pharma companies that you often hear about, but then there is also small biotech companies and medical technology companies, as well as many others.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
Rating
AXA Framlington Biotech R Acc235.62 GBP-2.96Rating
AXA Framlington Health R Acc2,677.97 GBP-1.87Rating
CVS Health Corp89.99 USD0.00Rating
Insulet Corp287.24 USD0.00Rating

About Author

Alanna Petroff

Alanna Petroff  is a financial journalist with Morningstar UK.